{"name":"Skye Bioscience, Inc.","slug":"skye-bioscience-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxNRDY1bFdJeFR3bjluRGtPeHAzYzhGMFFidnhSSTlOMTBSZHBZY3oxSjd5a3VlUl9SRWtIMWU5RzQzOFpGZFE2c1BiMGRsR3VhQktReUhlWjBUZmtkODJuN3pSZEtmSEUxV0pFY3hQX2JiUnc4N0F0Z2NYNkJ3dFFZdUtmM1k1QjhkUGJ6dTNjb2l2VGk3cGZwNXRiVEdnbjNTakpvQkFGZHJVLXlEU2lCVGpETTB3ZEZUeGlXY0lZeHZiWlRpaGc5QU5yQ2FxMVJDcVhsb3JpWlVPa01GNDRYbmlDWlV2dFpwZWZTWFM2TkR1TWxRU2J1WkVVOGZhRHY4blMxSGpXVEswQWRLenR4ZnljNm0zeVlBS0M4VnlDNlhTY28?oc=5","date":"2026-01-05","type":"deal","source":"prnewswire.com","summary":"Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity - prnewswire.com","headline":"Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated wit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNWjloRUNwT09LTGZFeXJtM2ExcVR2dXE4c1pXU3N0SHBrTUlFbENnTFVNTkFIOU15MHNINWo4RWZCVHR4S2lQTlBlWHMtMDVkMlZ1UmpheVJ4b0VVWEVBajNRZHpWNnZCT3pRWkt2b0RVX1BHUmRFMnYwakZmcUZYMzhyS042amNVWHRzVk1qSmw0UjRiZ2tTZGl0di03T2M4UHNZdTh4RmROVndYRzZfWXpiUQ?oc=5","date":"2026-01-05","type":"deal","source":"Contract Pharma","summary":"Skye Bioscience Licenses Halozyme’s ENHANZE Drug Delivery Technology - Contract Pharma","headline":"Skye Bioscience Licenses Halozyme’s ENHANZE Drug Delivery Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPaC1SSi1STlI4WlBuOFZ5dEJWNl9HRXhpS0E3dWFWdGVqMldhZVp4ZFIyUnVnYzJqSTFIYmF4LS0zbXJzRG8xakQ2NVJsRmtrTC10aHFhcmV4ck9PUk5Fakg3M19TRFlUaDFPa0F4eGlYVWVCY3AxZ0VCNlpPQko3NG84UDNSMkpwdEl4eW9fM2gyRkkyajZleQ?oc=5","date":"2025-10-06","type":"trial","source":"BioPharma Dive","summary":"Skye shares crash as obesity drug falls short in key study - BioPharma Dive","headline":"Skye shares crash as obesity drug falls short in key study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNV0ozbGJ4ajc2Ymd2bk9VRl91Sk9zVGJhMmVVMVJIOFJIQVdCZ1I0SXFtLUdpWnVqdkJxN3FFXzRfVWVtUXFPZ0NLd0ZfTmpPQzJPMzhuVFRVRFZ3LUtSUHVSdEFPbzdKTExBSXYxSWJjM1E4RHI2ZmZYVzBiY0oyYl9wRllEbHhwb3lFbGJjcF8yWHJSN3FFa1FiWDlRXzdMalhZ?oc=5","date":"2025-10-01","type":"trial","source":"Seeking Alpha","summary":"Skye Bioscience: Promising Nimacimab Data Supports Buy Rating (NASDAQ:SKYE) - Seeking Alpha","headline":"Skye Bioscience: Promising Nimacimab Data Supports Buy Rating (NASDAQ:SKYE)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-24","type":"pipeline","source":"simplywall.st","summary":"After losing 27% in the past year, Skye Bioscience, Inc. (NASDAQ:SKYE) institutional owners must be relieved by the recent gain - simplywall.st","headline":"After losing 27% in the past year, Skye Bioscience, Inc. (NASDAQ:SKYE) institutional owners must be relieved by the rece","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPbUtfLUhyTWpRM2VhVGVHYUVOTzNKNHVobEJlVDBvX1pBN1NwQ1Faa1o2NTdacnpzQVpkZER6NUtCMTNRVGtBQi1zOFVXVDhZTERPVkJ4Q0RhN3o5RVRRY0l4OWlhNm9nVjM1WnlqbGpiQmtSa2NWclpEcXNiWHAxOTlfUkV4VTE4OXk5MDBhaDJTZ0l1d09FOG11QXlWVk5JUmc0UU00MzJmMmdkVnp5bndGWE04ZVpscWZvd2p1MA?oc=5","date":"2025-05-07","type":"earnings","source":"Stock Titan","summary":"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025 - Stock Titan","headline":"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQR01aaVZ5NXJxZ0d4LTNRM0VGR1p0Z3lzeDg4WUxSNFdacEthMnEzLTRJdm9OMXNNLUpLZUhSekMtQlFRdXhudlVsTng4dWQtZlVvTWlKal8tenlqcFd5bXUyekJuYl9zUXJZUlBmVk5XRHh4cFFJelZ6VUVsRjVYQ0pR?oc=5","date":"2025-03-25","type":"pipeline","source":"The Pharma Letter","summary":"Skye Bioscience promotes Tu Diep to COO post - The Pharma Letter","headline":"Skye Bioscience promotes Tu Diep to COO post","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9zUWtuVjhORTQ1MVgwSHJRUy1XbjBKTlZOSTU5M3VJTEhwR1kwdl9xSUVqdkVFeTdIc2s4N053ay1oWmE3WThLam1NMWJkZmdHeUd6SHRtNTM0RzZyQUxKeWJtVHNKRHNYbC05TkpJZVlua2JOYnRB?oc=5","date":"2024-05-02","type":"pipeline","source":"Proactive Investors","summary":"Skye Bioscience Inc Share Price - SKYE, RNS News, Articles, Quotes, & Charts (NASDAQ: SKYE) - Proactive Investors","headline":"Skye Bioscience Inc Share Price - SKYE, RNS News, Articles, Quotes, & Charts (NASDAQ: SKYE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE9HNWs0MDdpcHBGMjNaWFpjR242eW9JVHBLcEw1UUQzMXZUX2JzZHpfaEpBQlVPdF9KTXp4eHluc3Z4WWtzQ0UwS3BNMUI3cTNR?oc=5","date":"2024-04-12","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE9VX3AxWXdwakRKVkR2RDZQVVFhb3JmZkpueE9jaXJOY1M5QjJuOFFYODhLbmE4SWJJcExMSkRodlJhaHJTdzZsQmU2TjFpd0E2Y0FtNGRFbFNlSTZs?oc=5","date":"2024-04-11","type":"pipeline","source":"TradingView","summary":"SKYE Stock Price and Chart — NASDAQ:SKYE - TradingView","headline":"SKYE Stock Price and Chart — NASDAQ:SKYE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNSDc5aGY2d2RvaGZOZmVyLVBTS3NMOVF1VUFxVDFVZmh1S2kwZzl4V0VzX2dpUUhyclROc2JSNFd4V1VsQ2R1NXpBRGRMSjIxOEJpMjBkLWVHY1p0UDIyUUthU0VvZm8zU3dMOW54LU80X3VBazJyN2RFRWdTQk9FM3ZZdm5pNHplcnAyYjFQNDdLY2hvV1RROGd6YzVJY1Y5WTk1OE5la1l0VW1pSzFzN3FJTHhRb2NqQnhlVEZxeHlRaE1zVEdwVUdURE9qMmFLMVJfTUpMeGpjY09JMU5XN2ZLZ01XRkVOTlhnQTR0dzZxc2FFV3RKT3l1dUxtRDJ6?oc=5","date":"2023-02-25","type":"trial","source":"Ophthalmology Times","summary":"Skye Bioscience receives positive safety review of topical cannabinoid receptor type 1 agonist after second cohort of phase 1 study - Ophthalmology Times","headline":"Skye Bioscience receives positive safety review of topical cannabinoid receptor type 1 agonist after second cohort of ph","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOb3ZtWXUzMnJpQW5xY3hNZkJJT3UzZTJ0OFRZbFdqUm1FbVcwVjBGQkc3eWFJWWZhSUVXNThLeDhBM0c0b3haQWxORF90X05LS2xiLXF0TERySWZGVGFpVDR1SnB4T1BqUjFmYk82RE5lTWthaVFDbHA0RGQteDZDR18tZDZ3TzNmUjB4OTB1NDhRUQ?oc=5","date":"2022-11-10","type":"pipeline","source":"Yahoo Finance","summary":"Skye Bioscience Closes Acquisition of Emerald Health Therapeutics - Yahoo Finance","headline":"Skye Bioscience Closes Acquisition of Emerald Health Therapeutics","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}